摘要 |
PCT No. PCT/EP98/03139 Sec. 371 Date Mar. 27, 2000 Sec. 102(e) Date Mar. 27, 2000 PCT Filed May 22, 1998 PCT Pub. No. WO98/52915 PCT Pub. Date Nov. 26, 1998Leukotriene-B4 derivatives of general formula (I), in which R1 represents H, CF3, CH2OH, and R2 represents H or an organic acid radical; R3 symbolizes H, C1-C14 alkyl, C3-C10 cycloalkyl, or a 5- to 6-membered aromatic heterocyclic ring with at least 1 heteroatom; R4 means hydrogen, C1-C10 alkyl, C3-C10 cycloalkyl; A symbolizes a trans, trans-CH=CH-CH=CH, a -CH2CH2-CH=CH- or a tetramethylene group; B symbolizes a C1-C10- straight-chain or branched-chain alkylene group or group (a) or (b); D can mean a direct bond, oxygen, sulfur, -C 3BOND C-, -CH=CR7, or together with B can also mean a direct bond; R5 and R6 are the same or different and represent H or C1-C4 alkyl, or R6 represents H and R5 represents C1-C15 alkanoyl or R8 represents SO2; R7 means H, C1-C5 alkyl, chlorine, bromine; R8 has the same meaning as R3, m means 1-3, o means 0-5, p means 0-5, X is a direct bond, oxygen, sulfur, an aromatic compound or heteroaromatic compound, Y is a C1-C8 alkyl, C3-C10 cycloalkyl, n is 2-5, and, if R4 means hydrogen, their salts with physiologically compatible bases and their cyclodextrin clathrates. The leukotriene derivatives are used as dermatological products.
|
申请人 |
SCHERING AKTIENGESELLSCHAFT |
发明人 |
BUCHMANN, BERND;FROHLICH, WOLFGANG;GIESEN, CLAUDIA;HENNEKES, HARTWIG;JAROCH, STEFAN;SKUBALLA, WERNER |